Home>>Signaling Pathways>> Cancer Biology>>(R)-M3913

(R)-M3913

Catalog No.GC73528

(R)-M3913(compound C-155) is a enantiomer of M3913.

Products are for research use only. Not for human use. We do not sell to patients.

(R)-M3913 Chemical Structure

Cas No.: 2379783-61-4

Size Price Stock Qty
10mM (in 1mL DMSO)
$584.00
In stock
1 mg
$241.00
In stock
5 mg
$531.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of (R)-M3913

(R)-M3913(compound C-155) is a enantiomer of M3913. M3913 is an antitumor compound. M3913 has antiproliferation activity against cancer cells.

References:
[1]. Yu Henry, et al. Preparation of substituted oxazepanyl pyrimidinamines as antiproliferation compounds. United States, US20190322658 A1. 2019-10-24.

Chemical Properties of (R)-M3913

Cas No. 2379783-61-4 SDF
Formula C17H21ClN4O3S M.Wt 396.89
Solubility DMSO : 100 mg/mL (251.96 mM; Need ultrasonic) Storage -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of (R)-M3913

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.5196 mL 12.5979 mL 25.1959 mL
5 mM 0.5039 mL 2.5196 mL 5.0392 mL
10 mM 0.252 mL 1.2598 mL 2.5196 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of (R)-M3913

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reviews

Review for (R)-M3913

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-M3913

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.